STOCK TITAN
  1. Home
  2. News
  3. ERPY

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
-
Positive
  • None.
Negative
  • None.

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Attachment


Stock ERPY logo
ERPY

:ERPY

ERPY Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

ERPY Latest News

Oct 9, 2023
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
Oct 4, 2023
PHAXIAM Receives Compliance Notice from Nasdaq
Oct 3, 2023
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration
Sep 21, 2023
PHAXIAM Provides Business and Financial Update For the First Half of 2023
Sep 19, 2023
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target

ERPY Stock Data